CIK: 0001735070
Total reported value
—
Reporting period: 2022-09-30 · Number of holdings: 1
DCVC Bio GP, LLC disclosed 1 holdings in its latest 13F filing for the period ending 2022-09-30, with total reported value of — and a quarterly turnover rate of 0.0%.
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Terms of Use for AI
AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/13f/dcvc-bio-gp-llc
No holding changes this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend | |
|---|---|---|---|---|---|---|---|---|
| 1 | ABCL | Abcellera Biologics INC | Stock-Other | — | — | -100.00% |
Not enough priced holdings yet to compute performance
Not enough sector-mapped data yet
| Period | Holdings | Total value | Stability | Top holdings | |
|---|---|---|---|---|---|
| 2022-09-30 | 1 | — | 0 | ||
| 2022-06-30 | 1 | $313.0K | 0 | ||
| 2022-03-31 | 1 | $71.2M | 0 | ||
| 2021-12-31 | 1 | $104.5M | 0 |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0000048966
Total reported value
—
1 stks
2024-12-31
Stale — no recent filing
CIK 0000056822
Total reported value
—
1 stks
2019-12-31
Stale — no recent filing
CIK 0000083402
Total reported value
—
1 stks
2021-09-30
Stale — no recent filing
Access DCVC Bio GP, LLC's institutional profile programmatically:
REST API
curl https://alphasmo.com/api/v1/institutions/dcvc-bio-gp-llcCLI
npx alphasmo institutions get dcvc-bio-gp-llc